| 1.3 |
5.3 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 1.3 |
10.5 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 1.2 |
3.5 |
GO:0007521 |
muscle cell fate determination(GO:0007521) cellular response to parathyroid hormone stimulus(GO:0071374) positive regulation of macrophage apoptotic process(GO:2000111) |
| 1.0 |
4.8 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 1.0 |
2.9 |
GO:0019043 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) establishment of viral latency(GO:0019043) |
| 0.9 |
0.9 |
GO:2000277 |
positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
| 0.8 |
2.3 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.8 |
2.3 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 0.8 |
7.5 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.7 |
2.8 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 0.7 |
2.0 |
GO:1905065 |
hematopoietic stem cell migration(GO:0035701) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
| 0.6 |
1.8 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.6 |
2.4 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.6 |
1.8 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.6 |
3.0 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.6 |
1.8 |
GO:1902277 |
negative regulation of pancreatic amylase secretion(GO:1902277) |
| 0.6 |
2.8 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.6 |
7.3 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.6 |
1.7 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.5 |
3.3 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.5 |
4.6 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.5 |
2.5 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.5 |
1.5 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.4 |
2.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.4 |
1.3 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.4 |
6.9 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.4 |
2.1 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.4 |
2.5 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.4 |
1.6 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) general adaptation syndrome(GO:0051866) |
| 0.4 |
2.0 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.4 |
1.2 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.4 |
1.9 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.4 |
1.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.4 |
4.0 |
GO:0071225 |
cellular response to muramyl dipeptide(GO:0071225) |
| 0.4 |
0.7 |
GO:0032701 |
negative regulation of interleukin-18 production(GO:0032701) |
| 0.4 |
0.7 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.4 |
1.1 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) phosphate ion transmembrane transport(GO:0035435) |
| 0.3 |
1.0 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.3 |
2.8 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.3 |
0.7 |
GO:0019086 |
late viral transcription(GO:0019086) |
| 0.3 |
2.0 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.3 |
1.3 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.3 |
1.6 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.3 |
1.9 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.3 |
1.6 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 |
0.9 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.3 |
0.9 |
GO:0072425 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.3 |
1.5 |
GO:2001204 |
regulation of osteoclast development(GO:2001204) |
| 0.3 |
1.2 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.3 |
2.3 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.3 |
0.8 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.3 |
0.3 |
GO:0002432 |
granuloma formation(GO:0002432) |
| 0.3 |
2.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.3 |
0.8 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.3 |
1.5 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
1.3 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.2 |
1.5 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.2 |
0.7 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.2 |
1.0 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.2 |
4.1 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.2 |
1.0 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.2 |
0.7 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.2 |
1.4 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.2 |
10.2 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.2 |
1.4 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 0.2 |
1.4 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.2 |
1.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.2 |
0.9 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.2 |
0.9 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 |
2.2 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.2 |
1.3 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.2 |
0.9 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.2 |
2.7 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.2 |
1.4 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.2 |
2.0 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.2 |
1.6 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.2 |
0.6 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 |
0.6 |
GO:0001803 |
antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
| 0.2 |
1.7 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.2 |
1.4 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.2 |
1.4 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.2 |
1.3 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
1.3 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.2 |
1.1 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 |
2.0 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.2 |
1.6 |
GO:1902285 |
semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.2 |
0.4 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 0.2 |
2.1 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.2 |
2.2 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.2 |
0.5 |
GO:0070944 |
neutrophil mediated killing of bacterium(GO:0070944) |
| 0.2 |
1.1 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.2 |
2.4 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.2 |
1.1 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.2 |
0.8 |
GO:0015871 |
choline transport(GO:0015871) regulation of resting membrane potential(GO:0060075) |
| 0.2 |
1.4 |
GO:0045724 |
positive regulation of cilium assembly(GO:0045724) |
| 0.2 |
4.3 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.2 |
0.3 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 |
1.8 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.2 |
1.5 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
0.8 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
| 0.2 |
1.4 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
1.2 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 0.1 |
2.2 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
0.4 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) alveolar secondary septum development(GO:0061144) |
| 0.1 |
7.0 |
GO:0047496 |
vesicle transport along microtubule(GO:0047496) |
| 0.1 |
1.9 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.1 |
GO:0043313 |
regulation of neutrophil degranulation(GO:0043313) |
| 0.1 |
0.6 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.1 |
0.7 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
1.4 |
GO:0032096 |
negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 |
1.0 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.4 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.1 |
0.4 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 |
1.8 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.1 |
0.4 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.1 |
0.9 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
1.3 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.1 |
1.5 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
2.0 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
1.0 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 |
0.5 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.2 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.1 |
0.5 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
0.3 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 |
2.6 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.1 |
0.5 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.1 |
2.8 |
GO:0001893 |
maternal placenta development(GO:0001893) |
| 0.1 |
0.7 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.6 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
0.9 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 |
3.4 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
0.7 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.5 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.8 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 |
5.1 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.1 |
1.7 |
GO:0007095 |
mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.1 |
0.2 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
0.8 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 |
0.5 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
1.6 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
0.8 |
GO:0071044 |
histone mRNA catabolic process(GO:0071044) |
| 0.1 |
0.3 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 |
0.5 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.1 |
0.7 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
6.5 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.1 |
0.6 |
GO:1900164 |
nodal signaling pathway involved in determination of left/right asymmetry(GO:0038107) regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry(GO:1900094) nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900164) |
| 0.1 |
2.0 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
1.4 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 |
0.8 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.1 |
0.7 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 |
1.9 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.1 |
0.3 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 |
0.3 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.1 |
1.6 |
GO:0000731 |
DNA synthesis involved in DNA repair(GO:0000731) |
| 0.1 |
0.4 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.1 |
5.8 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.1 |
0.3 |
GO:1902661 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) negative regulation of histone H4-K16 acetylation(GO:2000619) |
| 0.1 |
0.2 |
GO:0097278 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
1.0 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.1 |
0.6 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
1.3 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.2 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
1.5 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
1.7 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.1 |
0.6 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.1 |
1.3 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.1 |
0.1 |
GO:2000646 |
positive regulation of receptor catabolic process(GO:2000646) |
| 0.1 |
0.8 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.8 |
GO:0042554 |
superoxide anion generation(GO:0042554) |
| 0.1 |
1.1 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.1 |
1.5 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.1 |
0.3 |
GO:0086013 |
membrane repolarization during cardiac muscle cell action potential(GO:0086013) membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.1 |
2.3 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 |
0.8 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.1 |
1.0 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.1 |
0.6 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.1 |
3.1 |
GO:0007585 |
respiratory gaseous exchange(GO:0007585) |
| 0.1 |
0.3 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 |
0.2 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
0.5 |
GO:0044144 |
regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.1 |
0.8 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
1.5 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
0.4 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.1 |
1.6 |
GO:1900078 |
positive regulation of cellular response to insulin stimulus(GO:1900078) |
| 0.1 |
0.4 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.1 |
0.2 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.1 |
1.4 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
0.9 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
0.2 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.1 |
0.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.5 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.4 |
GO:0010950 |
positive regulation of endopeptidase activity(GO:0010950) positive regulation of peptidase activity(GO:0010952) |
| 0.1 |
0.2 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.5 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 |
7.0 |
GO:0035023 |
regulation of Rho protein signal transduction(GO:0035023) |
| 0.0 |
0.2 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.0 |
1.4 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.0 |
0.3 |
GO:0098789 |
positive regulation of mRNA 3'-end processing(GO:0031442) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 |
0.6 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.0 |
2.4 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
1.3 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.2 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.6 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 |
0.5 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.0 |
0.2 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.0 |
1.7 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.0 |
0.4 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.0 |
0.2 |
GO:2000491 |
positive regulation of hepatic stellate cell activation(GO:2000491) |
| 0.0 |
1.3 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.0 |
0.0 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.0 |
0.3 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.0 |
0.2 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 |
1.2 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.2 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
0.4 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.0 |
2.4 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
1.4 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.0 |
0.3 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.0 |
1.2 |
GO:0006110 |
regulation of glycolytic process(GO:0006110) |
| 0.0 |
0.3 |
GO:0032464 |
positive regulation of protein homooligomerization(GO:0032464) |
| 0.0 |
0.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
1.4 |
GO:0071346 |
cellular response to interferon-gamma(GO:0071346) |
| 0.0 |
1.4 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
| 0.0 |
0.5 |
GO:0042345 |
regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.0 |
0.5 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.0 |
0.8 |
GO:0006308 |
DNA catabolic process(GO:0006308) |
| 0.0 |
0.2 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
1.7 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.0 |
0.0 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.0 |
2.2 |
GO:1901379 |
regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.0 |
0.3 |
GO:0002689 |
negative regulation of leukocyte chemotaxis(GO:0002689) |
| 0.0 |
0.1 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
0.9 |
GO:0021522 |
spinal cord motor neuron differentiation(GO:0021522) |
| 0.0 |
0.3 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.5 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
| 0.0 |
0.5 |
GO:0030204 |
chondroitin sulfate metabolic process(GO:0030204) |
| 0.0 |
0.2 |
GO:0090085 |
regulation of protein deubiquitination(GO:0090085) |
| 0.0 |
0.1 |
GO:0032962 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
| 0.0 |
1.7 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.3 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 0.0 |
1.4 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.0 |
0.2 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.0 |
0.6 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.0 |
0.3 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.0 |
0.7 |
GO:0070301 |
cellular response to hydrogen peroxide(GO:0070301) |
| 0.0 |
0.3 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
0.8 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.0 |
0.5 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
| 0.0 |
0.6 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.5 |
GO:0098927 |
early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.0 |
0.4 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.0 |
0.1 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.0 |
0.1 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.0 |
0.3 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.0 |
0.2 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.0 |
0.3 |
GO:0050927 |
positive regulation of positive chemotaxis(GO:0050927) |
| 0.0 |
0.6 |
GO:0042993 |
positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.0 |
0.2 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.0 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.0 |
0.1 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.0 |
0.1 |
GO:0010988 |
regulation of low-density lipoprotein particle clearance(GO:0010988) |
| 0.0 |
0.4 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.0 |
1.6 |
GO:0010506 |
regulation of autophagy(GO:0010506) |
| 0.0 |
1.7 |
GO:0010977 |
negative regulation of neuron projection development(GO:0010977) |
| 0.0 |
0.1 |
GO:0014816 |
skeletal muscle satellite cell differentiation(GO:0014816) |
| 0.0 |
0.4 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.0 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 |
0.0 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.0 |
0.2 |
GO:0060261 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.0 |
0.2 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.0 |
0.3 |
GO:0010591 |
regulation of lamellipodium assembly(GO:0010591) |
| 0.0 |
0.2 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.4 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.2 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.0 |
0.7 |
GO:0045665 |
negative regulation of neuron differentiation(GO:0045665) |
| 0.0 |
0.0 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
